Welcome to the Washington State Medical Oncology Society Website

The purpose of the Washington State Medical Oncology Society (WSMOS) is:

  • To promote the highest professional standards of oncology practice in the state of Washington.
  • To study, research and exchange information, experiences and ideals leading to improvement in the practice of oncology.
  • To represent the practice of oncology and hematology in the state of Washington.

Regularly Monitor the WSMOS Website for:

  • WSMOS meetings & events
  • Legislative updates
  • Billing & reimbursement updates
  • Resources & tools
  • Oncology news
  • Newsletter
  • Practice Pattern Changes Survey

May 3, 2019 WSMOS Membership Meeting Presentations:

The Future of AI in Medicine and Oncology
Jeff Elton, CEO Concerto HealthAI

Interventional Pharmacoeconomics: A New Discipline for a Cost-Constrained Environment
Mark Ratain, MD Univ. of Chicago

Data Analytics and the OCM:
Mike Fazio, VP of Client Services, Archway


Sibel Blau, MD, NWMS, & 
Amy Ellis, Director Quality and Value Based Care, NWMS 


All the Data Collected on You and How It's Being Used
Richard Aries, MSN, RN-BC, Senior Data Administrator, Swedish Medical Center

The Incidence of and Risk Factors for Thromboembolism in Older Patients with Newly Diagnosed Multiple Myeloma
Ang Li, MD, 
Univ. of WA/Fred Hutchinson Cancer Research Center

Outcomes of Patients with Large B-Cell Lymphomas and Progressive Disease Following CD19-Specific CAR T-Cell Therapy
Victor Chow, MD, Univ. of WA/Fred Hutchinson Cancer Research Center

July 21, 2018 MAC JF/JE Caucus Presentations:

340B - Jeffery C. Ward

Johnson & Johnson 2017 Transparency Report and Response to Blueprint - Michael Barnard - Director, Federal Affairs

Are Drug Prices Too High? If so, Why? - Geoffey Joyce, PhD, University of Southern California

Drug Prices & Patient Costs - Veena Shankaran, MD, MS, HICOR, Fred Hutchinson Cancer Research Center and University of Washington

Medicare Update - Dick Whitten, MD, FACP, Contractor Medical Director, Noridian

Diamond Partners See All

  • Abbvie
  • Alexion
  • Amgen
  • Astellas Pharma US
  • Bayer Healthcare
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • Celgene
  • Coherus BioSciences
  • Eisai, Inc.
  • Genetech BioOncology
  • Genomic Health
  • Heron Therapeutics
  • Lilly Oncology
  • Merck
  • Pfizer Oncology
  • Sandoz Oncology
  • Taiho Oncology
  • Takeda
  • Teva Oncology